Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.
(Reuters Health) - - In men with localized prostate cancer discovered because they had symptoms or noticed during a work-up for another medical problem, radical prostate surgery leads to an average of ...
TORONTO, March 13, 2026 (GLOBE NEWSWIRE)-- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, ...
As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...
The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...
For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence. Despite its benefits, many ...
Primary endpoint analysis at 1 year showed better maintenance of erectile function and pad-free continence with TULSA than with robotic radical prostatectomy. Peri-procedural metrics favored TULSA, ...
Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...
Many men leave the hospital prostate cancer-free but unprepared for the slow pace of erectile recovery. Here's what to expect when returning to sex and intimacy.
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results